Concepedia

Thierry Fischmann

TF

Statistics

Publications

46

Citations

4K

H-Index

27

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Institut Pasteur

WuXi AppTec (China)

United States Military Academy

Thierry Fischmann is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1988–2024

46

Publications

46

Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor

David Parry, Timothy J. Guzi, Nicole R. Davis et al. · Molecular Cancer Therapeutics · 2010 · 561 citations · Full text

, , +17

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Thierry Fischmann, Alan Hruza, Xiao Da Niu et al. · Nature Structural Biology · 1999 · 456 citations

, , +10

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 417 citations

, , +11

Crystal Structure of <i>lac</i> Repressor Core Tetramer and Its Implications for DNA Looping

Alan M. Friedman, Thierry Fischmann, Thomas A. Steitz · Science · 1995 · 296 citations

, , +17

Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding

Thirumaleshwara N. Bhat, G.A. Bentley, Thierry Fischmann et al. · Nature · 1990 · 247 citations

, , +15

1–5 of 46